3 March 2024
Effica Health is preparing to launch virtual, clinician-led menopause care in Alberta and Ontario, beginning with a friends-and-family group to refine the care model before opening to a wider audience
Comparison with Standard Treatments Studies comparing BPC-157 to becaplermin (the active ingredient in Regranex, an FDA-approved treatment for diabetic foot ulcers) found BPC-157 produced superior results in several parameters
For the broader cosmetic OEM workflow including formulation development, stability testing, and regulatory support, see our GHK-Cu formulation guide and med-spa buyer's playbook.
We believe that fibroblast-based cell therapy can be both clinically beneficial and commercially attractive for patients with the disease
Glutathione Depletion: How NYCs Urban Environment Accelerates Antioxidant Loss New York City, while a vibrant hub of activity, exposes its residents to unique environmental and lifestyle stressors that can lead to a hidden deficiency: glutathione depletion